Current Pharmaceutical Design, Volume 21 - Number 17

Meet the Editorial Board

, 21(17): 2167

Gregory Y.H. Lip

DOI: 10.2174/138161282117150430124606


Editorial (Thematic Issue: Rheumatology: An Evolutionary force in Biologics)

, 21(17): 2168 - 2169

Matthew A. Sleeman

DOI: 10.2174/1381612821999150313162300

Rheumatoid Arthritis: An Evolutionary Force in Biologics

, 21(17): 2170 - 2178

Philip M. Brown and John D. Isaacs

DOI: 10.2174/1381612821666150310141827

Rheumatology: A Force for Change in Monoclonal Antibodies

, 21(17): 2179 - 2186

David C. Lowe and Tristan J. Vaughan

DOI: 10.2174/1381612821666150310142202

Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside

, 21(17): 2187 - 2197

Xiao Liu, Andrew J. Teichtahl and Ian P. Wicks

DOI: 10.2174/1381612821666150310143332

Finding a Place for Interleukin-1 Inhibitors in the Treatment of Rheumatologic Diseases

, 21(17): 2198 - 2205

Donna Finch and Matthew Sleeman

DOI: 10.2174/1381612821666150310144603

Biological Therapies in Osteoarthritis

, 21(17): 2206 - 2215

Claire Y.J. Wenham, Michael McDermott and Philip G. Conaghan

DOI: 10.2174/1381612821666150310144940

Towards a Stratified Targeted Approach with Biologic Treatments in Rheumatoid Arthritis: Role of Synovial Pathobiology

, 21(17): 2216 - 2224

Elisa Astorri, Alessandra Nerviani, Michele Bombardieri and Costantino Pitzalis

DOI: 10.2174/1381612821666150310145758

The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE

, 21(17): 2225 - 2235

Shaun M. Flint, Eoin F. McKinney, Paul A. Lyons and Kenneth G.C. Smith

DOI: 10.2174/1381612821666150313130256

Microrna-21: A Central Regulator of Fibrotic Diseases Via Various Targets

, 21(17): 2236 - 2242

Ying Huang, Yong He and Jun Li

DOI: 10.2174/1381612820666141226095701

25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages

, 21(17): 2243 - 2249

Harald Mangge, Sieglinde Zelzer, Andreas Meinitzer, Ingeborg Stelzer, Wolfgang J. Schnedl, Daniel Weghuber, Dietmar Fuchs, Teodor T. Postolache, Elmar Aigner, Christian Datz and Eva Z. Reininghaus

DOI: 10.2174/1381612821666150105160931

Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design

, 21(17): 2250 - 2258

Janos Tajti, Zsofia Majlath, Delia Szok, Anett Csati, Jozsef Toldi, Ferenc Fulop and Laszlo Vecsei

DOI: 10.2174/1381612821666150105163055

Treatment of Leishmaniasis: A Review and Assessment of Recent Research

, 21(17): 2259 - 2275

Ehab Kotb Elmahallawy and Ahmad Agil

DOI: 10.2174/1381612821666141231163053

CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment

, 21(17): 2276 - 2283

Karin Tamas, Urszula M. Domanska, Tonnis H. van Dijk, Hetty Timmer-Bosscha, Klaas Havenga, Arend Karrenbeld, Wim J. Sluiter, Jannet C. Beukema, Marcel A.T.M. van Vugt, Elisabeth G.E. de Vries, Geke A.P. Hospers and Annemiek M.E. Walenkamp

DOI: 10.2174/1381612821666150105155615

Therapeutic Effect of Ghrelin in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis

, 21(17): 2284 - 2290

J. Bukowczan, Z. Warzecha, P. Ceranowicz, B. Kusnierz-Cabala, R. Tomaszewska and A. Dembinski

DOI: 10.2174/1381612821666150105152553

Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms

, 21(17): 2291 - 2303

Laszlo G. Harsing Jr., Julia Timar, Geza Szabo, Szabolcs Udvari, Katalin M. Nagy, Bernadett Marko, Gabriella Zsilla, Andrea Czompa, Pal Tapolcsanyi, Akos Kocsis and Peter Matyus

DOI: 10.2174/1381612821666150109125623

Webmaster Contact:
Copyright © 2018 Bentham Science